TLMDW (SOC Telemed) YoY EBITDA Growth: 0.00% (As of Dec. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TLMDW SOC Telemed Inc TLMDW
19 GF Score
Price $0.84
! 6 Warning Signs
View Full Analysis

What is SOC Telemed YoY EBITDA Growth?

SOC Telemed TLMDW 19 YoY EBITDA Growth is 0.00% as of Dec. 2021. GuruFocus rates TLMDW with a GF Score™ of 19/100. The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. SOC Telemed's YoY EBITDA Growth for the quarter that ended in Dec. 2021 was 0.00%.

SOC Telemed's EBITDA per Share for the six months ended in Dec. 2021 was $0.00.

SOC Telemed YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for SOC Telemed's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOC Telemed YoY EBITDA Growth Chart

SOC Telemed Annual Data
Trend Dec19 Dec20 Dec21
YoY EBITDA Growth
0.00 0.00 0.00

SOC Telemed Semi-Annual Data
Dec19 Dec20 Dec21
YoY EBITDA Growth 0.00 0.00 0.00
TLMDW
19GF Score
SOC Telemed Inc TLMDW
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SOC Telemed YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

SOC Telemed's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(-)/ | |
=N/A %

SOC Telemed's YoY EBITDA Growth for the quarter that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (Q: Dec. 2021 )
=(EBITDA per Share (Q: Dec. 2021 )-EBITDA per Share (Q: Dec. 2020 )) / | EBITDA per Share (Q: Dec. 2020 ) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
SOC Telemed (TLMDW) has a YoY EBITDA Growth of 0.00% as of Dec. 2021. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for SOC Telemed and its competitors.
Is SOC Telemed's YoY EBITDA Growth too high?
SOC Telemed's current YoY EBITDA Growth is 0.00%. Overall, SOC Telemed has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SOC Telemed's YoY EBITDA Growth compare to PHCI and JYNT?
SOC Telemed's YoY EBITDA Growth of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for SOC Telemed and its competitors. SOC Telemed's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOC Telemed stock overvalued right now?
SOC Telemed (TLMDW) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. SOC Telemed's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For SOC Telemed (TLMDW), the current YoY EBITDA Growth is 0.00% as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SOC Telemed Business Description

Address 1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190
SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.
19GF Score

Get the complete analysis for TLMDW

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.84
Price